Corresponding Author: Michael Levin, MD, Department of Infectious Diseases, Imperial College London, Norfolk Place, London, Greater London W21NY, United Kingdom (email@example.com).
Accepted for Publication: May 29, 2020.
Published Online: June 8, 2020. doi:10.1001/jama.2020.10369
Correction: This article was corrected online June 30, 2020, to fix the numbers and percentages of patients in certain groups reported in the Results section of the Abstract and text and Table 2, as well as add names to the list of group investigators in Supplement 2.
Author Contributions: Drs Whittaker and Kaforou had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Whittaker, Bamford, Kenny, and Kaforou contributed equally. Drs Lyall and Levin contributed equally.
Concept and design: Whittaker, Bamford, Jones, Kucera, McDougall, Carter, Lyall, Levin.
Acquisition, analysis, or interpretation of data: Whittaker, Bamford, Kenny, Kaforou, Jones, Shah, Ramnarayan, Fraisse, Miller, Davies, Brierley, McDougall, Carter, Tremoulet, Shimizu, Herberg, Burns.
Drafting of the manuscript: Whittaker, Bamford, Kenny, Kaforou, Jones, Miller, Davies, Kucera, Levin.
Critical revision of the manuscript for important intellectual content: Whittaker, Bamford, Kenny, Kaforou, Jones, Shah, Ramnarayan, Fraisse, Brierley, McDougall, Carter, Tremoulet, Shimizu, Herberg, Burns, Lyall, Levin.
Statistical analysis: Whittaker, Kaforou, Shah, Shimizu.
Obtained funding: Whittaker, Kaforou, Tremoulet, Shimizu, Herberg, Burns, Levin.
Administrative, technical, or material support: Kenny, Kaforou, Jones, McDougall, Carter, Levin.
Supervision: Kaforou, Fraisse, McDougall, Lyall, Levin.
Conflict of Interest Disclosures: Dr Fraisse reported consultantship and proctoring for transcatheter congenital interventions from Abbott, Occlutech, and Medtronic. Dr Shimizu reported receiving grants from the Gordon and Marilyn Macklin Foundation. No other disclosures were reported.
Funding/Support: Drs Kaforou, Whittaker, Shah, Herberg, and Levin receive support from the UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre. Dr Kaforou is funded by the Wellcome Trust (Sir Henry Wellcome Fellowship grant 206508/Z/17/Z). This project received funding from the European Union’s Seventh Framework programme under grant agreement 279185 (EUCLIDS) and the European Union’s Horizon 2020 research and innovation programme under grant agreement 668303 (PERFORM). Dr Burns, Tremoulet, and Shimizu were supported in part by grant R01HL140898 from the National Institutes of Health. This work is supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The views expressed are those of the author(s) and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health.
Additional Contributions: This work would not have been possible without collaboration between 3 NIHR biomedical research center facilities: Great Ormond Street, Imperial College London, and Guy’s & St Thomas’.
J , Poirault
C , Corsia
et al. Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France. medRxiv
. Preprint posted May 2020. doi:10.1101/2020.05.10.20097394
L , Mazza
A , Gervasoni
et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet
. Published online May 13, 2020. doi:10.1016/S0140-6736(20)31103-XPubMedGoogle Scholar
BW , Rowley
AH , Newburger
et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation
. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484PubMedGoogle ScholarCrossref